D. E. Shaw & Co., Inc. Abcam PLC Transaction History

D. E. Shaw & Co., Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$21.54 - $24.41 $19.6 Million - $22.2 Million	909,807 Added 126.82%	1,627,188 $36.8 Million
Q2 2023 Aug 14, 2023	BUY	$12.62 - $24.47 $4.91 Million - $9.51 Million	388,723 Added 118.28%	717,381 $17.6 Million
Q1 2023 May 15, 2023	SELL	$12.98 - $17.1 $4.08 Million - $5.38 Million	-314,515 Reduced 48.9%	328,658 $4.42 Million
Q4 2022 Feb 14, 2023	BUY	$13.92 - $17.0 $8.95 Million - $10.9 Million	643,173 New	643,173 $10 Million

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.